fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - epilepsialääkkeet, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
surmontil 50 mg tabletti, kalvopäällysteinen
sanofi-aventis oy - trimipramini maleas - tabletti, kalvopäällysteinen - 50 mg - trimipramiini
surmontil embonat 5 mg/ml mikstuura
rhone-poulenc rorer a/s - trimipramini embonas - mikstuura - 5 mg/ml - trimipramiini
surmontil 10 mg tabletti
rhone-poulenc rorer a/s - trimipramini maleas - tabletti - 10 mg - trimipramiini
droglican 200 mg / 250 mg kapseli, kova
laboratorio reig jofrÉ, s.a. - sodium chondroitin sulphate, glucosamine hydrochloride - kapseli, kova - 200 mg / 250 mg - muut spesifiset reumalääkkeet
amaryl 3 mg tabletti
sanofi oy - glimepiride - tabletti - 3 mg - glimepiridi
amaryl 4 mg tabletti
sanofi oy - glimepiride - tabletti - 4 mg - glimepiridi
glimepirid orion 1 mg tabletti
orion corporation - glimepiridum - tabletti - 1 mg - glimepiridi
glimepirid orion 2 mg tabletti
orion corporation - glimepiridum - tabletti - 2 mg - glimepiridi
glimepirid orion 3 mg tabletti
orion corporation - glimepiridum - tabletti - 3 mg - glimepiridi